Journal article

Thalidomide-analogue biology: immunological, molecular and epigenetic targets in cancer therapy

J Shortt, AK Hsu, RW Johnstone

Oncogene | NATURE PUBLISHING GROUP | Published : 2013

DOI: 10.1038/onc.2012.599

Citation metrics

52Web of Science
62Scopus
57Dimensions

Keywords

Necrosis-Factor-Alpha
Natural-Killer-Cell
Cell Biology
Antineoplastic Agents
Neoplasms
Lenalidomide-Induced Immunomodulation
Life Sciences & Biomedicine
Genetics & Heredity
T Regulatory Cells
Science & Technology
Human-Immunodeficiency-Virus
Epigenesis, Genetic
Chromosome Deletion
Immunomodulation
Immune Modulation
Thalidomide
Oncology
Commonly Deleted Region
Immunologic Factors
In-Vitro
Hematological Malignancies
Nf-Kappa-B
Therapeutics
Diamond-Blackfan Anemia
Animals
Multiple Myeloma
Myelodysplastic Syndromes
Biochemistry & Molecular Biology
Multiple-Myeloma Cells
Chromosomes, Human, Pair 5
Humans